Real-time enrollment status for this secondary hemophagocytic lymphohistiocytosis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:17 AM UTC
| NCT Number | NCT05416307 |
| Recruiting Status | Recruiting |
| Condition | Secondary Hemophagocytic Lymphohistiocytosis |
| Phase | PHASE2 |
| Target Enrollment | 156 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Electra Therapeutics Inc. |
| Last Updated on CT.gov | May 26, 2026 (May 26, 2026) |
As of July 17, 2026: Clinical trial NCT05416307 is currently recruiting participants. This phase2 study for secondary hemophagocytic lymphohistiocytosis is actively seeking new participants at 18 locations across the United States. The study is sponsored by Electra Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05416307 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05416307 was last updated May 26, 2026 (May 26, 2026). HelloStudys verifies this status automatically.